Rho-Associated Kinase Activity Is a Predictor of Cardiovascular Outcomes

Rho-Associated Kinase Activity, Endothelial Function, and Cardiovascular Risk Factors

(2011) Junko Soga et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension

(2011) N Fujimura et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Enhanced Rho-Kinase Activity in Circulating Neutrophils of Patients With Vasospastic Angina

(2011) Yoku Kikuchi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice

(2010) Jing Ding et al.   JOURNAL OF NEUROCHEMISTRY

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Statins inhibit Rho kinase activity in patients with atherosclerosis

(2008) Anju Nohria et al.   ATHEROSCLEROSIS

Increased leukocyte ROCK activity in patients after acute ischemic stroke

(2008) Steven K. Feske et al.   BRAIN RESEARCH

ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury

(2008) Kensuke Noma et al.   JOURNAL OF CLINICAL INVESTIGATION

Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model

(2007) Shin-ichi Satoh et al.   BRAIN RESEARCH